RHEA BUYCKS: Open Payments
NPI 1013288687 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 30 payments from 12 companies in 2025. Trend: 2023 $340 · 2024 $624 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $204 |
| Xeris Pharmaceuticals, Inc. | 5 | $175 |
| Otsuka America Pharmaceutical, Inc. | 5 | $168 |
| Novo Nordisk Inc | 7 | $159 |
| Boston Scientific Corporation | 1 | $117 |
| Amgen Inc. | 2 | $43 |
| Verona Pharma, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Electromed, Inc. | 3 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: GVOKE HYPOPEN, ABILIFY MAINTENA, BREZTRI, Intracept, Ozempic, AIRSUPRA, Rybelsus, OTEZLA.
Industry payments across OK — which companies pay providers there.
